We are a biologics company committed to translating science into medicines that transform the lives of patients with various diseases.
About Vitro
Vitro Biopharma is an innovative biotechnology company focused on developing Wharton's jelly-derived cell therapies for autoimmune diseases and inflammatory disorders. Our goal is to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market.
Scalable Manufacturing
We manufacture under strict environmental and laboratory controls in accordance with cGMP. We are cGMP compliant and CLIA certified, with a QMS that is globally recognized as ISO 9001:2015 and ISO 13485:2016 certified. With 30 years of research and by leveraging the biological advantages of UC-derived MSCs, we believe we may have a significant cost and competitive advantage over our competitors, within our scalable and standardized manufacturing process.
Subscribe To Our Newsroom
Keep up to date with Vitro Biopharma, Inc.